BIOA: BioAge Labs, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Cormorant Asset Management, LP | 5.38% | SEC |
Institutional ownership (Q2 2026)
150 institutions reported holding $918.41M of BioAge Labs, Inc. on Form 13F (144 the quarter before). 27 opened a new position and 19 sold out. Shares held by institutions: +10%.
| Largest holders | Shares | Value |
|---|---|---|
| a16z Capital Management, L.L.C. | 3,233,170 | $79.24M |
| BlackRock, Inc. | 2,849,077 | $69.83M |
| Cormorant Asset Management, LP | 2,390,605 | $58.59M |
| Sofinnova Investments, Inc. | 2,293,788 | $56.22M |
| Jupiter Topco LLC | 2,144,633 | $52.60M |
| Octagon Capital Advisors LP | 1,748,000 | $42.84M |
| RA CAPITAL MANAGEMENT, L.P. | 1,671,648 | $40.97M |
| MPM BIOIMPACT LLC | 1,667,661 | $40.87M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,544,214 | $37.85M |
| Polar Capital Holdings Plc | 1,072,344 | $26.28M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.